DAC_ICARUS_BREAST01

Dr BARBARA PISTILLI
barbara.pistilli@gustaveroussy.fr

Request Access

Dataset ID	Description	Technology	Samples
EGAD50000000773	A phase II clinical trial (NCT04965766) of patritumab deruxtecan in 99 breast cancer patients. Whole-exome sequencing (WES) is available for 43 tumor samples and 43 blood samples collected at entry into the trial. RNA-squencing is available for 44 samples comprising 22 samples collected at entry into the trial and 22 samples collected during treatment (cycle 1 day 3, cycle 1 day 19, or cycle 2 day 3) from 22 patients.	Illumina NovaSeq 6000	136